Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement
Hanbit Park, Do-Yoon Kang, Jung-Min Ahn, Kyung Won Kim, Anthony Y T Wong, Simon C C Lam, Wei-Hsian Yin, Jeng Wei, Yung-Tsai Lee, Hsien-Li Kao, Mao-Shin Lin, Tsung-Yu Ko, Won-Jang Kim, Se Hun Kang, Euihong Ko, Dae-Hee Kim, Hyun Jung Koo, Dong Hyun Yang, Joon-Won Kang, Seung Chai Jung, Jae-Hong Lee, Sung-Cheol Yun, Seung-Jung Park, Duk-Woo Park
BMJ Open Jan 2021, 11 (1) e042587; DOI: 10.1136/bmjopen-2020-042587